Loading...
Loading...
Pharmaceutical Importer Β· #6 buyer for Pioglitazone Β· $1.8M import value Β· 171 shipments Β· UNITED STATES Β· DGFT Verified
NORTHSTAR DISTRIBUTION CENTER 8912 is the #6 importer of Pioglitazone from India with $1.8M in import value and 171 verified shipments. NORTHSTAR DISTRIBUTION CENTER 8912 holds a 4.8% market share in Pioglitazone imports based in UNITED STATES. The company sources from 1 verified supplier across 93 formulations shipped to 2 countries. Overall, NORTHSTAR DISTRIBUTION CENTER 8912 imports 35 pharmaceutical products worth $80.5M across 17 therapeutic categories.

Verified from 171 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MACLEODS PHARMACEUTICALS LIMITED | $1.8M | 171 | 100.0% |
NORTHSTAR DISTRIBUTION CENTER 8912 sources Pioglitazone from 1 verified Indian supplier based on 171 customs records. The primary supplier is MACLEODS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #6 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | RISING PHARMA HOLDINGS INC | UNITED STATES | $2.2M | 45 | $49.6K |
| 5 | AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $2.1M | 52 | $41.0K |
| 6 | NORTHSTAR DISTRIBUTION CENTER 8912 β | UNITED STATES | $1.8M | 171 | $10.4K |
| 7 | AUROLOGISTICS LLC | UNITED STATES | $1.3M | 43 | $29.1K |
| 9 | AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $919.3K | 25 | $36.8K |
NORTHSTAR DISTRIBUTION CENTER 8912 ranks #6 among 293 Pioglitazone importers from India. Average shipment value of $10.4K compared to the market average of $71.8K. The closest competitors by value are RISING PHARMA HOLDINGS INC and AUROLOGISTICS LLC, (AUROBINDO PHARM.
Destination countries from 171 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.7M | 166 | 96.1% |
| UNITED STATES OF AMERICA | $69.3K | 5 | 3.9% |
NORTHSTAR DISTRIBUTION CENTER 8912 imports Pioglitazone to 2 countries. The primary destination is UNITED STATES receiving 96.1% of shipments worth $1.7M.
| Formulation | Value | Shipments |
|---|---|---|
| DRUG&PHA.HARMLESS MED.-PIOGLITAZONE TAB. | $172.0K | 6 |
| DRUG&PHA.HARMLES MED.-PIOGLITAZONE TABLE | $123.0K | 11 |
| DRUG&PHA.HARMLES MED-PIOGLITAZONE TAB.USP 15MG 500NSTR-NDC.NO.16714-645-03B.N:BPF2321B2323A2322AM/D.09-23E/D.08.28 | $50.0K | 1 |
| DRUG PHA HARMLES MED PIOGLITAZONE HYDROCHLORIDE TABS USP 15MG NDC 16714 645 03 B N 14251381A 14251383A M D 4 25 E D 3 30 | $50.0K | 1 |
| DRUG&PHA.HARMLES MED-PIOGLITAZONE TABLETS USP 30MG (90S)-NDC NO.16714-646-02B/N.14240099A/14240100AM.D.04/24E.D.03/27 | $42.3K | 1 |
| DRUG&PHA.HARMLES MED-PIOGLITAZONE TABLETS USP 30MG(90S)-NDC NO.16714-646-02,B/N.14242811A/14242812A,M.D.11/24,E.D.:10/27 | $41.1K | 1 |
| PIOGLITAZONE TAB.USP 15MG 500 NSTR-NDC NO.16714-645-03-ECONO#2627925,B/N:14250423A,14250424A MFG DT:01/25 EXP DT:12/29 | $40.1K | 1 |
What NORTHSTAR DISTRIBUTION CENTER 8912 and other importers must comply with to import Pioglitazone from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10β18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $21.0M worth of Pioglitazone through 2,674 shipments from 115 suppliers to 70 countries, serving 293 buyers globally. NORTHSTAR DISTRIBUTION CENTER 8912 imports $1.8M of this total, accounting for 4.8% of India's Pioglitazone exports with 171 shipments from UNITED STATES. This is verified from 171 customs shipment records covering 93 distinct formulations.
NORTHSTAR DISTRIBUTION CENTER 8912's average Pioglitazone order value is $10.3K per consignment, based on 171 shipments totaling $1.8M. NORTHSTAR DISTRIBUTION CENTER 8912 is based in UNITED STATES and ranks #6 among all Pioglitazone importers from India by value. The company sources from 1 verified supplier in India.
NORTHSTAR DISTRIBUTION CENTER 8912 sources Pioglitazone from 1 verified Indian supplier: MACLEODS PHARMACEUTICALS LIMITED ($1.8M, 100.0%). This is based on 171 customs records.
NORTHSTAR DISTRIBUTION CENTER 8912 ranks #6 among 293 Pioglitazone importers from India with a 4.8% market share. The top 3 importers are RISING PHARMA HOLDINGS, INC. ,. ($2.8M), RISING PHARMA HOLDINGS, INC. ($2.6M), AUROLOGISTICS LLC (AUROBINDO PHARMA ($2.4M). NORTHSTAR DISTRIBUTION CENTER 8912 processed 171 shipments from UNITED STATES.
NORTHSTAR DISTRIBUTION CENTER 8912 imports 35 products worth $80.5M. Beyond Pioglitazone, top products include Rosuvastatin, Omeprazole, Clopidogrel, Metoprolol, Amoxicillin. View the complete NORTHSTAR DISTRIBUTION CENTER 8912 profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Pioglitazone β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for NORTHSTAR DISTRIBUTION CENTER 8912's Pioglitazone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NORTHSTAR DISTRIBUTION CENTER 8912
Full Company Profile β
35 products Β· $80.5M total trade Β· 17 categories
| DRUG&PHA.HARMLES MED-PIOGLITAZONE TABLETS USP15MG 500NSTR-NDC NO.16714-645-03,B/N.14242702A/14242701A,M.D.10/24,E.D.9/29 |
| $39.3K |
| 1 |
| DRUG&PHA.HARMLES MED-PIOGLITAZONE TABLET | $36.6K | 3 |
| DRUG&PHA.HARMLES MED-PIOGLITAZONE TABLETS USP 30MG 500NSTR-NDC-16714-646-03 B.N:BPG2313A MFG DT.JUN-2023 EXP DT.MAY-2026 | $26.1K | 1 |
NORTHSTAR DISTRIBUTION CENTER 8912 imports 93 distinct Pioglitazone formulations from India. The top formulation is DRUG&PHA.HARMLESS MED.-PIOGLITAZONE TAB. with 6 shipments worth $172.0K.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 70+ countries, 293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for NORTHSTAR DISTRIBUTION CENTER 8912.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pioglitazone. For current order-level data, contact TransData Nexus.